Seraxis to Provide Oral Update on Its Pancreatic Organoid Candidate for Functional Cure of T1D at th
Dr. William Rust will give an oral presentation on Seraxis’ proprietary technology for the production of therapeutic pancreatic organoids from pancreas-derived stem cells, as well as review initial diabetes model data of functional cure of Type 1 Diabetes. Seraxis’ presentation, entitled “Stem-cell Derived Islets fo...
United States Ted Hibben William Rust Seraxis Inc Corporate Development European Association For The Study Of Diabetes
Source: pharmiweb.com